JAMES O ARMITAGE, MD
Osteopathic Medicine at Nebraska Medical Ctr, Omaha, NE
License number
Nebraska 12643
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
988102 Nebraska Medical Ctr, Omaha, NE 68198
Phone
(402) 559-9800
(402) 559-4835 (Fax)
(402) 559-4835 (Fax)
Personal information
See more information about JAMES O ARMITAGE at radaris.comName
Address
Phone
21402 Hancock Dr, Gretna, NE 68028
14522 Charles St, Omaha, NE 68154
301 Oak Ridge Dr, Bellevue, NE 68005
3716 94Th Cir, Omaha, NE 68124
2603 87Th St, Omaha, NE 68124
Organization information
See more information about JAMES O ARMITAGE at bizstanding.comNebraska Medical Center - James O Armitage MD
988102 Nebraska Medical Ctr, Omaha, NE 68198
Categories:
Dentists, Hematology Physicians & Surgeons, Physicians & Surgeons
Site:
Phone:
(402) 559-5600 (Phone)
Professional information
Dr. James O Armitage - MD (Doctor of Medicine)
Hospitals:
University NE Med Ctr Hem Onclg
987680 Nebraska Medical Ctr, Omaha 68198
Nebraska Medical Cancer Center
988095 Nebraska Medical Ctr SUITE 3, Omaha 68198
Nebraska Medical Center Cancer
988102 Nebraska Medical Ctr, Omaha 68198
University NE Med Ctr Hem Onclg
987680 Nebraska Medical Ctr, Omaha 68198
Nebraska Medical Cancer Center
988095 Nebraska Medical Ctr SUITE 3, Omaha 68198
Nebraska Medical Center Cancer
988102 Nebraska Medical Ctr, Omaha 68198
987680 Nebraska Medical Ctr, Omaha 68198
Nebraska Medical Cancer Center
988095 Nebraska Medical Ctr SUITE 3, Omaha 68198
Nebraska Medical Center Cancer
988102 Nebraska Medical Ctr, Omaha 68198
University NE Med Ctr Hem Onclg
987680 Nebraska Medical Ctr, Omaha 68198
Nebraska Medical Cancer Center
988095 Nebraska Medical Ctr SUITE 3, Omaha 68198
Nebraska Medical Center Cancer
988102 Nebraska Medical Ctr, Omaha 68198
Education:
Medical Schools
University of Nebraska / College of Medicine
Graduated: 1973
University of Nebraska / College of Medicine
Graduated: 1973
James O Armitage, Omaha NE
Specialties:
Oncologist
Address:
4400 Emile St, Omaha, NE 68198
987680 Nebraska Medical Ctr, Omaha, NE 68198
988102 Nebraska Medical Ctr, Omaha, NE 68198
987680 Nebraska Medical Ctr, Omaha, NE 68198
988102 Nebraska Medical Ctr, Omaha, NE 68198
Education:
University of Nebraska, College of Medicine - Doctor of Medicine
Nebraska Medical Center, The - Residency - Internal Medicine
Nebraska Medical Center, The - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine), American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
James O Armitage, Omaha NE
Specialties:
Internal Medicine, Hematology, Medical Oncology, Hematology & Oncology
Work:
Omaha - Va Nebraska-Western Iowa Health Care System
4101 Woolworth Ave, Omaha, NE 68105 University of Nebraska
987680 Nebraska Medical Ctr, Omaha, NE 68198
4101 Woolworth Ave, Omaha, NE 68105 University of Nebraska
987680 Nebraska Medical Ctr, Omaha, NE 68198
Education:
University of Nebraska (1973)
Methods For Identifying, Diagnosing, And Predicting Survival Of Lymphomas
US Patent:
2007010, May 10, 2007
Filed:
Jul 25, 2006
Appl. No.:
11/493387
Inventors:
Louis Staudt - Silver Spring MD, US
George Wright - Rockville MD, US
Sandeep Dave - Washington DC, US
Bruce Tan - Baltimore MD, US
John Powell - Ijamsville MD, US
Wyndham Wilson - Washington DC, US
Elaine Jaffe - Great Falls VA, US
Wing Chan - Omaha NE, US
Timothy Greiner - Council Bluffs IA, US
Dennis Weisenburger - Elkhom NE, US
James Armitage - Omaha NE, US
Kai Fu - Omaha NE, US
Richard Fisher - Pittsford NY, US
Lisa Rimsza - Tucson AZ, US
Thomas Miller - Tucson AZ, US
Thomas Grogan - Tucson AZ, US
Elias Campo - Barcelona, ES
Silvia Bea - Sabadell, ES
Itziar Salaverria - Barcelona, ES
Armando Lopez-Guillermo - Barcelona, ES
Emili Montserrat - Barcelona, ES
Victor Moreno - Barcelona, ES
Andreas Zettl - Wurzburg, DE
German Ott - Wurzburg, DE
Hans-Konrad Muller-Hermelink - Wuerzburg, DE
Andreas Rosenwald - Wuerzburg, DE
Julie Vose - Omaha NE, US
Randy Gascoyne - North Vancouver, CA
Joseph Connors - Vancouver, CA
Erlend Smeland - Oslo, NO
Stein Kvaloy - Oslo, NO
Harald Holte - Oslo, NO
Jan Delabie - Oslo, NO
T. Andrew Lister - London, GB
George Wright - Rockville MD, US
Sandeep Dave - Washington DC, US
Bruce Tan - Baltimore MD, US
John Powell - Ijamsville MD, US
Wyndham Wilson - Washington DC, US
Elaine Jaffe - Great Falls VA, US
Wing Chan - Omaha NE, US
Timothy Greiner - Council Bluffs IA, US
Dennis Weisenburger - Elkhom NE, US
James Armitage - Omaha NE, US
Kai Fu - Omaha NE, US
Richard Fisher - Pittsford NY, US
Lisa Rimsza - Tucson AZ, US
Thomas Miller - Tucson AZ, US
Thomas Grogan - Tucson AZ, US
Elias Campo - Barcelona, ES
Silvia Bea - Sabadell, ES
Itziar Salaverria - Barcelona, ES
Armando Lopez-Guillermo - Barcelona, ES
Emili Montserrat - Barcelona, ES
Victor Moreno - Barcelona, ES
Andreas Zettl - Wurzburg, DE
German Ott - Wurzburg, DE
Hans-Konrad Muller-Hermelink - Wuerzburg, DE
Andreas Rosenwald - Wuerzburg, DE
Julie Vose - Omaha NE, US
Randy Gascoyne - North Vancouver, CA
Joseph Connors - Vancouver, CA
Erlend Smeland - Oslo, NO
Stein Kvaloy - Oslo, NO
Harald Holte - Oslo, NO
Jan Delabie - Oslo, NO
T. Andrew Lister - London, GB
International Classification:
C12Q 1/68, G06F 19/00
US Classification:
435006000, 702020000
Abstract:
Gene expression data provides a basis for more accurate identification and diagnosis of lymphoproliferative disorders. In addition, gene expression data can be used to develop more accurate predictors of survival. The present invention discloses methods for identifying, diagnosing, and predicting survival in a lymphoma or lymphoproliferative disorder on the basis of gene expression patterns. The invention discloses a novel microarray, the Lymph Dx microarray, for obtaining gene expression data from a lymphoma sample. The invention also discloses a variety of methods for utilizing lymphoma gene expression data to determine the identity of a particular lymphoma and to predict survival in a subject diagnosed with a particular lymphoma. This information will be useful in developing the therapeutic approach to be used with a particular subject.
Methods For Identifying, Diagnosing, And Predicting Survival Of Lymphomas
US Patent:
2012022, Sep 6, 2012
Filed:
Mar 1, 2012
Appl. No.:
13/409416
Inventors:
Louis M. Staudt - Silver Spring MD, US
George Wright - Rockville MD, US
Sandeep Dave - Washington DC, US
Bruce Tan - Baltimore MD, US
John I. Powell - Ijamsville MD, US
Wyndham Wilson - Washington DC, US
Elaine Jaffe - Great Falls VA, US
Wing C. Chan - Omaha NE, US
Timothy C. Greiner - Council Bluffs IA, US
Dennis Weisenburger - Elkhorn NE, US
James Armitage - Omaha NE, US
Kai Fu - Omaha NE, US
Richard I. Fisher - Pittsford NY, US
Lisa Rimsza - Tucson AZ, US
Thomas Miller - Tucson AZ, US
Thomas Grogan - Tucson AZ, US
Elias Campo - Barcelona, ES
Silvia M. Bea - Sabadell, ES
Itziar Salaverria - Barcelona, ES
Armando Lopez-Guillermo - Barcelona, ES
Emili Montserrat - Barcelona, ES
Victor Moreno - Barcelona, ES
Andreas Zetti - Wurzburg, DE
German Ott - Wurzburg, DE
Hans-Konrad Muller-Hermelink - Wuerzburg, DE
Andreas Rosenwald - Wuerzburg, DE
Julie Vose - Omaha NE, US
Randy Gascoyne - North Vancouver, CA
Joseph Connors - Vancouver, CA
Erlend Smeland - Oslo, NO
Stein Kvaloy - Oslo, NO
Harald Holte - Oslo, NO
Jan Delabie - Oslo, NO
T. Andrew Lister - London, GB
George Wright - Rockville MD, US
Sandeep Dave - Washington DC, US
Bruce Tan - Baltimore MD, US
John I. Powell - Ijamsville MD, US
Wyndham Wilson - Washington DC, US
Elaine Jaffe - Great Falls VA, US
Wing C. Chan - Omaha NE, US
Timothy C. Greiner - Council Bluffs IA, US
Dennis Weisenburger - Elkhorn NE, US
James Armitage - Omaha NE, US
Kai Fu - Omaha NE, US
Richard I. Fisher - Pittsford NY, US
Lisa Rimsza - Tucson AZ, US
Thomas Miller - Tucson AZ, US
Thomas Grogan - Tucson AZ, US
Elias Campo - Barcelona, ES
Silvia M. Bea - Sabadell, ES
Itziar Salaverria - Barcelona, ES
Armando Lopez-Guillermo - Barcelona, ES
Emili Montserrat - Barcelona, ES
Victor Moreno - Barcelona, ES
Andreas Zetti - Wurzburg, DE
German Ott - Wurzburg, DE
Hans-Konrad Muller-Hermelink - Wuerzburg, DE
Andreas Rosenwald - Wuerzburg, DE
Julie Vose - Omaha NE, US
Randy Gascoyne - North Vancouver, CA
Joseph Connors - Vancouver, CA
Erlend Smeland - Oslo, NO
Stein Kvaloy - Oslo, NO
Harald Holte - Oslo, NO
Jan Delabie - Oslo, NO
T. Andrew Lister - London, GB
Assignee:
The United States of America, as Represented by the Secretary, Dept. of Health and Human Services - Bethesda MD
Board of Regents of the University of Nebraska - Lincoln NE
University of Rochester - Rochester NY
Arizona Board of Regents on Behalf of the University of Arizona - Tucson AZ
Universitat De Barcelona - Barcelona
Queen Mary and Westfield College, University of London - London
Hospital Clinic - Barcelona
Julius-Maximilians-University of Wuerzburg - Wrzburg
British Columbia Cancer Agency Branch - Vancover
Oslo University Hospital HE - Oslo
Fundacio Clinic - Barcelona
Board of Regents of the University of Nebraska - Lincoln NE
University of Rochester - Rochester NY
Arizona Board of Regents on Behalf of the University of Arizona - Tucson AZ
Universitat De Barcelona - Barcelona
Queen Mary and Westfield College, University of London - London
Hospital Clinic - Barcelona
Julius-Maximilians-University of Wuerzburg - Wrzburg
British Columbia Cancer Agency Branch - Vancover
Oslo University Hospital HE - Oslo
Fundacio Clinic - Barcelona
International Classification:
C40B 30/04
US Classification:
506 9
Abstract:
Gene expression data provides a basis for more accurate identification and diagnosis of lymphoproliferative disorders. In addition, gene expression data can be used to develop more accurate predictors of survival. The present invention discloses methods for identifying, diagnosing, and predicting survival in a lymphoma or lymphoproliferative disorder on the basis of gene expression patterns. The invention discloses a novel microarray, the Lymph Dx microarray, for obtaining gene expression data from a lymphoma sample. The invention also discloses a variety of methods for utilizing lymphoma gene expression data to determine the identity of a particular lymphoma and to predict survival in a subject diagnosed with a particular lymphoma. This information will be useful in developing the therapeutic approach to be used with a particular subject.